2 Best 5-Star Rated Dynamic Asset Allocation Funds For SIP In 2021

[ad_1]

Read More/Less


Should I start SIP In Dynamic Asset Allocation funds?

Based on the market movements, Dynamic asset allocation funds, also known as balanced advantage funds, actively manage their allocation towards equity and debt stocks. As a result, investing in these funds can give you a long-term wealth potential as well as a cushion against the downside in case of falling equity markets.

According to the performance report of ICRA Analytics Ltd, Dynamic Asset Allocation Funds marked a three-month return of 5.51 percent, a six-month return of 10.14 percent, a one-year return of 26.1 percent, a three-year return of 11.37 percent, a five-year return of 9.74 percent, and a ten-year return of 12.15 percent as of September 30, 2021.

With a minimal risk exposure, these returns can be a decent approach for investors in a falling market scenario to start SIP in Dynamic asset allocation funds with an investment horizon of at least 3 years or more.

According to the data of ICRA Analytics Ltd, In September 2021, mutual fund contributions under the Systematic Investment Plan (SIP) surpassed Rs 10,000 for the first time, totaling Rs 10,351 crore, rising 13% from June 2021. SIP AUM climbed by 8% in September 2021 after reaching the Rs. 5 lakh crore milestone in July 2021.

SIP AUM was Rs. 5.45 lakh crore at the end of the quarter, rising roughly 13% over the previous quarter. It accounted for 15% of total industry assets, while SIP accounts increased by 12% to 4.49 crore. Hence, we would like to suggest our readers stick to their SIPs or start SIP in Dynamic Asset Allocation Funds to welcome the takeaways into their portfolio like the power of compounding, rupee cost averaging, and low initial investment.

Edelweiss Balanced Advantage Fund Direct-Growth

Edelweiss Balanced Advantage Fund Direct-Growth

Edelweiss Balanced Advantage Fund Direct-Growth returns of the last 1-year are 29.10%. Since launch, it has delivered 13.65% average annual returns, according to the data of the fund house as of 18 Nov 2021. The equity side of the fund is predominantly engaged in the financial, technology, energy, fast-moving consumer goods, and automobile sectors. ICICI Bank Ltd., Reliance Industries Ltd – PPE, National Bank For Agriculture & Rural Development, Infosys Ltd., and Nifty 50 are the fund’s top five holdings.

The fund has a 0.45 percent expense ratio, which is lower than most other funds in the same category. The fund now has a 59.90 percent equity allocation and a 20.09 percent debt exposure. As of 30 September 2021, Edelweiss Balanced Advantage Fund Direct-Growth has Rs 6,331 crores in assets under management (AUM), and the fund’s NAV was 39.35 crores as of 18 Nov 2021. Value Research has given the fund a 5-star rating, and you may start investing in it with Rs 500 SIP.

Performance as on 18 Nov 2021 Scheme Scheme Benchmark CRISIL Hybrid 50+50 – Moderate Index Additional Benchmark NIFTY 50 – TRI
Period Return (CAGR) Return (CAGR) Return (CAGR)
1 Year 29.10% 23.56% 38.88%
3 Year 18.83% 16.09% 19.82%
5 Year 16.18% 13.59% 18.52%
Since Inception – Existing Plan 13.65% 9.41% 14.17%
Source: edelweissmf.com

Kotak Balanced Advantage Fund Direct Growth

Kotak Balanced Advantage Fund Direct Growth

Kotak Balanced Advantage Fund Direct has a one-year return rate of 19.96 percent. According to the date of the fund house as of 18.11.2021, it has generated 13.26% average annual returns since its inception. The fund has its equity allocation across the Financial, Metals, Services, Technology, Energy sectors. The fund’s top five holdings are GOI, ICICI Bank Ltd., Adani Ports and Special Economic Zone Ltd., and Infosys Ltd. The fund has a 0.45 percent expense ratio, which is lower than most other Dynamic Asset Allocation funds.

The fund now has a 78.73 percent equity allocation and a 21.27 percent debt exposure. Kotak Balanced Advantage Fund Direct-Growth had Rs 11,813.44 crores in assets under management (AUM) as of 30 September 2021, and the fund’s NAV was Rs 15.07 crores as of 18 November 2021. The fund has a 5-star rating from Value Research, and you can start SIP with Rs 500.

Tenors Since Inception Last 5 Year Last 3 Years Last 1 Year
Kotak Balanced Advantage Fund – Direct (G) 13.26% 15.02% 19.96%
Nifty 50 Hybrid Composite Debt 50:50 Index 13.49% 13.43% 15.69% 20.87%
Nifty 50 TRI 15.87% 18.54% 19.88% 38.88%
Performance as of 18.11.2021. Source: kotakmf.com

Disclaimer

Disclaimer

The views and investment tips expressed by authors or employees of Greynium Information Technologies, should not be construed as investment advice to buy or sell stocks, gold, currency, or other commodities. Investors should certainly not take any trading and investment decision based only on information discussed on GoodReturns.in We are not a qualified financial advisor and any information herein is not investment advice. It is informational in nature. All readers and investors should note that neither Greynium nor the author of the articles, would be responsible for any decision taken based on these articles. Please consult a professional advisor. Greynium Information Technologies Pvt Ltd, its subsidiaries, associates, and authors do not accept culpability for losses and/or damages arising based on information in GoodReturns.in



[ad_2]

CLICK HERE TO APPLY

Buy This Small Cap Textile Stock For A Gain of 23% In 6 Months: HDFC Securities

[ad_1]

Read More/Less


Q2FY22 results of Siyaram Silk Mills Ltd according to HDFC Securities

  • SSML in Q2FY22 reported strong performance. Overall revenues stood at Rs. 480Cr which grew by 1.76x/1.06x on a YoY/QoQ basis. Segment-wise, branded Fabric, garments and yarn revenue for the quarter stood 80/16/4% respectively.
  • Fabric segment reported a volume of 23lk Mtrs which grew 70% on sequential basis while realization stood at Rs. 164/ mtr on QoQ basis registering a growth of 23% due to lower discounting and improved product mix.
  • Garments segment volumes for the quarter stood at 12lk pcs up 97% on QoQ basis while realization stood at Rs. 632 – up 20% on a QoQ basis while Yarn segment volume for the quarter stood at 6lk MT – up 6% on a QoQ basis while realization stood at Rs. 299.5/MT – up 8% on a QoQ basis.
  • EBITDA for the quarter stood at Rs.85 Cr v/s a loss of Rs. 6Cr in Q2FY21 while on a sequential basis EBITDA grew by 1.92x. SSML reported best ever operating performance for the quarter whereby it clocked highest ever quarterly EBITDA margin of 17.6% v/s 12.4% in Q1FY22.
  • Consequently, PAT for the quarter stood at Rs. 52Cr v/s a loss of Rs. 14Cr in Q2FY22. Sequentially it reported a growth of 3x in PAT over Q1FY22.

HDFC Securities Ltd’s take on SSML

HDFC Securities Ltd’s take on SSML

The brokerage in its research report has said that “Siyaram Silk Mills Ltd (SSML) has one of the most prudent capital allocation track record in the textile and apparel space in India. Despite the covid-19 pandemic-related turmoil, it operated at a Net D/E of 0.1x as of FY21. It has been in a constant endeavor to establish itself as an asset light and a pure branded fabric and apparel player in the highly commoditized and working capital intensive textile industry. SSML is one of the largest poly-viscose blended fabric players in India. Its portfolio of products include suiting fabrics, shirting fabrics, casual and formal apparels and home furnishing. SSML has registered a smart recovery in earnings post the 2nd covid-19 wave whereby it reported best ever quarterly performance in Q2FY22.”

HDFC Securities has further clarified that “In Q2FY22, it reported a PAT of Rs. 52Cr which was mainly driven by strong operating leverage and its lean cost structure. SSML has positioned its products mainly in the mid-market whereby it competes directly with unorganized and regional fabric players. Its strong balance sheet, deep penetration with a consistent and focused approach toward brand building were the key growth drivers for the company. Over FY10-20, it had undergone a cumulative investment of ~Rs. 600Cr behind A&P activities which accounts for 4% of its cumulative revenues. Key demand drivers like social gatherings, marriage season and festivals are likely to play out in H2FY22.”

Buy Siyaram Silk Mills with a target price of Rs 559

Buy Siyaram Silk Mills with a target price of Rs 559

The brokerage has claimed in its research report that “In our view, SSML’srevenue and EBITDA are likely to record a growth of 23% and 73% CAGR over FY21-24E while PAT for FY24E is likely to reach Rs. 183Cr v/s Rs. 3.5Cr in FY21 and Rs.69Cr in FY20. Along with this, we expect the company to benefit from strong operating leverage and generate consistent FCF with improvement in working capital and ROCE from 7% in FY20 to 19% by FY24E”.

HDFC Securities has reported in its research report that “Given the healthy growth outlook and a strong set of numbers in Q2FY22, we reiterate our positive view on the stock and expect the stock to further get re-rated. Consequently, we have now revised earnings and increased the target price for SSML. We feel investors can buy the stock in the band of Rs. 460-465 and further add-on dips at Rs. 410 for a base case fair value of Rs. 503 (13.5x Sept FY23E) and bull case fair value of Rs. 559 (15x Sept FY23E) for a time horizon of 2 quarters.”

Disclaimer

Disclaimer

The stock has been picked from the brokerage report of HDFC Securities Ltd. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

Stocks To Buy: Buy This Tractor Major Stock For 22% Upside In 1 Year, Says ICICI Direct

[ad_1]

Read More/Less


About Escorts:

Escorts is the country’s fourth largest tractor manufacturing entity with a market share of 11.3 percent. The company also caters to the domestic railways and construction equipment segment. Talking about its sales mix in FY21, tractors account for the major sales component.

Kubota Escorts transaction:

Kubota Escorts transaction:

The company will issue additional equity through the preferential allotment route to the Japanese tractor major Kubota Corporation for a price of Rs. 2000 per share with inflow of approximately Rs. 1873 crore.

In the transaction, Kubota’s shareholding in Escorts shall increase to 16.4 percent from 10 percent and the company will become a joint promoter of Escorts.

There is a proposal to change company name to Escorts Kubota Ltd.

All the current JV’s are planned to be merged.

Nanda family will retain its stake and Mr. Nikhil Nanda will continue to be the CMD.

Brokerage's advice on Escorts to investors

Brokerage’s advice on Escorts to investors

The scrip in the past 5 years has zoomed 6 times from levels of around Rs. 300 in November 2016, significantly outperforming Nifty Auto index. “We retain B U Y on Escorts with Kubota now a co-promoter with expectations of enhanced product offerings and increased global sourcing from India”, says the brokerage.

Target Price and Valuation: The brokerage values Escorts at revised SOTP-based TP of Rs. 2,200 (23x P/E on core FY23E EPS, 15% discount on treasury shares; previous TP- Rs. 1,900 )

Key triggers for future price performance:

Key triggers for future price performance:

• New product launches in the farm mechanisation side (ex-tractors).

• Optimum utilisation of surplus cash on b/s, currently nearly at Rs. 5,000 crore.

• Expect 13% tractor revenue CAGR over FY21-23E.

• Construction equipment, railways growth to be faster amid expected pickup in economic activity and positive outlook for user segments

Alternate Stock Idea:

Alternate Stock Idea:

Other than Escorts, the brokerage house in its auto OEM coverage is bullish on M&M. The company recommends buying the stock of M&M for a target price of Rs. 1125, potential upside of 21.75% from the last traded price of Rs. 923.7 per share. The brokerage highlights positives of M&M as prudent capital allocation, UV differentiation & EV proactiveness.

Disclaimer:

Disclaimer:

The above stock was picked from the brokerage report of ICICI Direct. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

‘Buy’ This Stock For 15% Returns In 1 Year: Edelweiss Recommends

[ad_1]

Read More/Less


Target Price

The Current Market Price (CMP) of Lumax Inds is Rs. 1,486. The brokerage firm, Edelweiss has estimated a Target Price for the stock at Rs. 1,710. Hence the stock is expected to give a 15% return, in a Target Period of 1 year.

Stock Outlook
Current Market Price (CMP) Rs. 1,486
Target Price Rs. 1,710
1 year return 15.00%

Company performance

Company performance

Lumax Inds reported a topline of Rs. 453 crore (which was ~7% above expectation). EBITDA stood at ~Rs. 37 crore, registering a growth of 10% YoY and ~4.8x on a QoQ basis. EBITDA margins for the quarter stood at 8.2% vis-à-vis 8.5% in Q2 FY21 and 2% in Q1 FY22. Edelweiss stated, “Although the company was able to sustain gross margin of 36% similar to the same quarter last fiscal; increase in employee cost and other expenses dragged EBITDA margins.”

Comments by Edelweiss

Comments by Edelweiss

According to Edelweiss, “As the issue of semi-conductor shortage eases from Oct-21, we expect production schedules for 2W/PV OEMs to normalize from Q4FY22. Further, we expect LED penetration for both 2Ws and 4Ws to also see an uptrend. Being the market leader in the automotive lighting space, LUMAX should be a major beneficiary of the LED transition. We maintain our ‘BUY rating with a target price of Rs. 1,710/share, valuing it at 18x FY23E EPS.”

About the company

About the company

Lumax accounts for over 60% market share in Indian Automobile Lighting Business. The group’s products include end-to-end Lighting solutions, Gear Shifters, Shift Towers, 2-wheeler Chassis, Intake Systems, Seat structures & Mechanisms, LED Lighting, HVAC Panels, Electrical & Electronic Components, Cables & Wiring Harness, Telematics Products and Services, Oxygen Sensors, and On-board Antennas among others.

Disclaimer

Disclaimer

The above stock was picked from the brokerage report of Edelweiss. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

HDFC Securities Recommends To ‘Buy’ This Cement Stock For 15% Returns In 1 Year

[ad_1]

Read More/Less


Target Price

The Current Market Price (CMP) of JK Cement is Rs. 3534, till November 20. The brokerage firm, HDFC Securities has estimated a Target Price for the stock at Rs. 4,070. Hence the stock is expected to give a 15% return, in a Target Period of 1 year.

Stock Outlook
Current Market Price (CMP) Rs. 3534
Target Price Rs. 4,070
1 year return 15.00%

Company performance

Company performance

JK Cement (JKCE) Q2FY22 EBITDA at Rs. 3.5bn (adjusted for Rs. 260mn impairment charge), down 14% YoY, was broadly in line with consensus estimates. The company’s standalone revenues are up 18% YoY to Rs. 18.0bn, broadly in line with estimates. Grey cement volumes including clinker sales increased 20% YoY and 6.6% QoQ. Management is targeting commissioning of 4 mnte Panna expansion at a CAPEX of Rs. 30 bn by Mar’23, which would drive strong ~15% volume CAGR over FY21-FY24E.

Comments by HDFC Securities

Comments by HDFC Securities

HDFC Securities said, “Our recent channel checks suggest companies have increased prices by Rs. 20-25/bag across regions. We maintain BUY on the stock with a revised target price of Rs. 4,070/sh (earlier: Rs. 3,700) based on 14x Dec’23E EV/E.” On the risks font, the brokerage firm mentioned the company’s lower demand/pricing.

About the company

About the company

JK Cement Ltd. is one of India’s leading manufacturers of Grey Cement. It has an installed Grey Cement capacity of 15 MnTPA, and JKCL is the No. 1 manufacturer of Wall Putty in the World and the third-largest manufacturer of White Cement, globally, with a total white cement capacity of 1.20 MnTPA and wall putty capacity of 1.2MnTPA. JK White Cement is sold across 43 countries.

Disclaimer

Disclaimer

The above stock was picked from the brokerage report of HDFC Securities. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

Punjab & Sind Bank Debuts “Swasth Bharat FD Scheme” With An Additional Rate of 0.15%

[ad_1]

Read More/Less


Investment

oi-Vipul Das

|

Punjab & Sind Bank (PSB) launches “Swasth Bharat TD Scheme” with an additional rate of interest of 0.15%. This term deposit scheme can be opened by individuals who have got at least one dose of COVID-19 vaccine. The scheme is valid up to 31.12.2021 and it can be opened by any Indian resident individual.

PSB Debuts “Swasth Bharat FD Scheme” With An Additional Rate of 0.15%

On its website, the bank has mentioned that “To give impetus to nationwide vaccination drive of the government and this product encourages the eligible customers to get themselves administered with Coronavirus vaccine either partially or fully, Bank has introduced new Swasth Bharat Scheme to provide offer of additional rate of Interest on the term deposits of the customers.”

Key takeaways of PSB Swasth Bharat FD Scheme

Eligibility: By submitting a government-issued vaccination certificate, any Indian Resident Individual (single/jointly/EorS) who has received at least one dose of Anti-Covid 19 Vaccine can open a PSB Swasth Bharat FD Scheme.

Tenure of Deposit: This term deposit scheme can be opened for a maturity period of above2 to less than 3 years only.

Amount of Fixed Deposit: One can open PSB Swasth Bharat FD Scheme with a minimum deposit amount of Rs. 1000/ and maximum of less than Rs 2 Cr.

Rate of interest: The rate of interest on the PSB Swasth Bharat FD Scheme will be 15 basis points more than the prevailing rate, with a quarterly compounding option. Senior citizens, employees, and ex-employees will continue to get their applicable additional rate of interest. On deposits of less than Rs 2 Cr maturing in above 2 years to less than 3 years, PSB is currently offering an interest rate of 5.15%, however, under the Swasth Bharat FD Scheme, the interest rate will be 5.30% respectively.

Validity: PSB Swasth Bharat FD Scheme is valid up to 31.12.2021.

Nomination: A nomination can only be filed in favour of one nominee only.

Punjab And Sind Bank FD Rates

On domestic term deposits, NRO accounts, capital gain accounts scheme 1988, recurring deposit scheme and PSB fixed deposit tax-saver schemes of less than Rs 2 Cr, the bank is offering the following interest rates with effect from 16/09/2021 (% p.a.).

Maturity Regular Interest Rates (% p.a.) Senior Citizens (% p.a.)
7 – 14 Days 3 3
15 – 30 Days 3 3
31 – 45 Days 3 3
46 – 90 Days 3.7 3.7
91 – 120 Days 3.9 3.9
121-150 Days 3.9 3.9
151 – 179 Days 3.9 3.9
180 – 269 Days 4.45 4.95
270 – 364 Days 4.5 5
1 Year – 2 Years 5.05 5.55
Above 2 Year 5.15 5.65
3 Years – 5 Years 5.3 5.8
> 5 Year – 10 Years 5.3 5.8
Source: Bank Website. Revised w.e.f. 16/09/2021

Story first published: Saturday, November 20, 2021, 12:14 [IST]



[ad_2]

CLICK HERE TO APPLY

“BUY” This Navratna Stock For A Gain of 53% Recommends ICICI Securities

[ad_1]

Read More/Less


Q2FY22 results of Engineers India Ltd.

According to the brokerage, the company’s “Execution on HPCL Barmer remained low as LSTK execution during Q2FY22 fell 12.3% YoY to Rs3bn. Consultancy execution was also subdued with a muted 1.8% YoY growth to Rs3.5bn over a low base. The margin for the segment contracted 156bps to 25.5%. For LSTK, although the margin expanded by 66bps, it remained low at 2.5%.”

ICICI Securities has stated in its research report that “The company provided Rs129mn during H1FY22 (Rs1.7bn in FY21) for any likely principal default under employee provident fund trust. This led to employee cost, as a proportion of sales, expanding 450bps hurting the overall margins, which declined 200bps YoY to 9.3%. Additionally, other income fell 47% YoY, further impacting the earnings, which shrunk 36% YoY.”

The broking firm also reported that the “Company won two large orders from CPCL Nagapattinam comprising of ~Rs10.4bn out of the total order inflow of Rs11.7bn in Q2FY22. With this, the total order book now stands at Rs80bn (2.4x TTM sales). Some large orders in the near term pipeline include one medium-sized order from Numaligarh; BPCL-related umbrella order of ~Rs2.5bn; HMEL’s petrochemical expansion (Rs6bn-7bn); and MRPL’s petchem expansion.”

Buy Engineers India Ltd with a target price of Rs 109

Buy Engineers India Ltd with a target price of Rs 109

ICICI Securities claims in its research report that “The current valuation at 11x FY22E and 13.6x FY23E earnings is benign given the strong balance sheet with 22% RoE projection for FY23E. Accounting for the high cash balance, we value the core business separately and add back the cash with 70% weightage factoring in the risk of any likely further investment towards asset ownership. Due to lower execution and muted earnings during Q2FY22, we cut our earnings estimates for FY22E and FY23E by 9% and 6% respectively.”

The brokerage has further added that “Given that the Ramagundam facility has commenced operations, we have also factored in the company’s 26% stake worth Rs4.5bn into our valuation as well as the investments in NELP and Numaligarh. We arrive at our target price of Rs109, implying a multiple of 15x to FY23E core earnings. Delay in order finalisation, loss of market share and delay in execution are some of the major risks to our view.”

Disclaimer

Disclaimer

The stock has been picked from the brokerage report of ICICI Securities Limited. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

This Mid Cap Pharma Stock Has 17% Upside In 1 Year, “BUY” Says ICICI Direct

[ad_1]

Read More/Less


Q2FY22 results of Ipca Laboratories Limited

According to the brokerage, the company’s “Revenues grew 13.5% YoY to Rs 1544.4 crore (I-direct estimate: Rs 1591crore). Strong YoY growth of 30.4% in domestic formulations to Rs 698.2 crore (I-direct estimate: Rs 621.2 crore) was offset by 3.7% YoY de-growth in export formulations to Rs 351 crore (I-direct estimate: Rs 404.5 crore) along with API sales decline of 5.6% YoY to Rs 359.7 crore (I-direct estimate: Rs 430.8 crore).”

ICICI Direct has said in its research report that the company’s “EBITDA margins declined 279 bps YoY to 23.7% (I-direct estimates of 24.4%) due to lower gross margins (down 272 bps YoY). Subsequently, EBITDA grew 1.5% YoY to Rs 365.6 crore (I-direct estimate: Rs 388.9 crore). Delta vis-à-vis I-direct estimates were mainly due to lower than expected topline performance and margins. PAT de-grew 6.3% YoY to Rs 250.2 crore (I-direct estimate: Rs 289.6 crore). Delta vis-à-vis EBITDA was mainly due to higher tax rate being partially offset by higher other income.”

Key triggers for future price performance of Ipca Laboratories Ltd. according to ICICI Direct

Key triggers for future price performance of Ipca Laboratories Ltd. according to ICICI Direct

  • Incremental growth in other therapies (excluding malaria), especially non-communicable diseases like pain management, cardio-diabetology, etc, the overall portfolio is poised for steady growth.
  • Sustained traction from branded and generics exports sales with a revival in EU is likely to mitigate the US void.
  • Commissioning of Devas plant and additional capacities from Ratlam.
  • US traction will take longer due to USFDA import alerts for the Ratlam facility that is the only API source for Silvassa and Pithampur formulations.

Q2FY22 Earnings Conference Call highlights of Ipca Laboratories Ltd According to ICICI Direct

Q2FY22 Earnings Conference Call highlights of Ipca Laboratories Ltd According to ICICI Direct

  • Domestic formulations grew 30.4% YoY: Segment wise YoY growth: Pain-management: 33%, cardio & antidiabetic: 13%, anti-bacterial: 37%, dermatology: 65%, antimalarial: 75%, cough & cold: 95%.
  • Segment wise percentage of revenue: Pain management: 47%, cardio & anti-diabetic: 17%, anti-bacterial: 8%, dermatology: 5%, anti-malarial: 7%, cough & cold: 4%.
  • Gross margins were affected by – Rise in raw material cost (in some cases two to threefold). The management has not indicated at any respite in inflated raw material cost and rise in packaging, logistic and power cost.
  • The management guided that Q3 would remain impacted for APIs with a possible recovery from Q4.
  • The management maintained its guidance for domestic business in FY22 while withholding the guidance of ~ 25% FY22 EBITDA margins.
  • Devas is expected to be operational in FY23 while the Ratlam facility will be operational by Q3FY22. API capacity will increase by 20% post-completion of both projects.

Buy Ipca Laboratories Ltd with a target price of Rs 2490

Buy Ipca Laboratories Ltd with a target price of Rs 2490

ICICI Direct in its research report has said that “Ipca’s share price has grown by ~4.3x over the past five years (from ~Rs 488 in June 2016 to ~Rs 2121 levels in November 2021). Maintain BUY due to good traction in domestic formulations and sustainable growth amid some margin pressure in the medium term.”

“Quarterly performance gyrations notwithstanding, the company remains a decent player with a judicious mix of strong domestic franchise and a spread out exports model with a healthy balance sheet. Going ahead, with firm growth tempo in domestic formulations, good prospects both for API exports, formulation exports, we expect further improvement in financial parameters” ICICI Direct claims.

“We value Ipca at Rs 2490 i.e. 26x P/E on FY23E EPS” the brokerage has said.

Disclaimer

Disclaimer

The above stock was picked from the brokerage report of ICICI Securities Limited. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

Crypto Currency Vs Gold: Which is A Better Investment?

[ad_1]

Read More/Less


Hedge Against inflation?

What would you say if I tell you that in 7 Years the value of Cash that you hold will become half?

Investors view bitcoin as digital gold and a hedge against inflation, expecting it to appreciate over time over-performing the current inflation rate. The same stands for Gold but it has not performed well in the past few years.

Below are 4 features that makes Bitcoin not just similar but a better asset than Gold

● Rarity: Bitcoin is rare. It cannot be created at will; there are only 21 million of them, and no one can create more. That means that no government can control it or fake it. No one is going to create more gold which will be feasible.The scarcity of gold changes depending on how much you put into finding it.

● Durability – Both bitcoins and gold are almost perfectly durable. As long as the internet operates, bitcoin will be in use. As far back as it can be traced, gold has been used to make jewelry, trade, etc.

● Divisibility – Bitcoin can be divided into individual satoshis, with 100,000,000 satoshis making up 1 BTC. Gold cannot be divided as easily or as precisely but it can be minted in smaller denominations

● They are hard to fake – Bitcoin and gold can’t be counterfeited and duplicated. Bitcoin is easy to recognize and impossible to counterfeit. Gold is pretty recognizable, though it must be tested for purity under some circumstances.

Conclusion

Conclusion

Gold can give you insurance against inflation and overvalued stock markets. Crypto analysts and experts believe that Bitcoin is the most asymmetric investment opportunity on the face of the planet right now. The upside in investing in Bitcoin is so much higher than the potential downside, that no other investment even comes close.

Manoj Dalmia, is the Founder and Director, Proaasetz Exchange.

Disclaimer

Disclaimer

Investing in crypto currencies is extremely risky and investors are advised caution. It also remains largely unregulated in India. Investors must therefore exercise due caution. Greynium Information Technologies Pvt Ltd the author not liable for any losses caused as a result of decisions based on the article. Investors should seek professional advise before investment.



[ad_2]

CLICK HERE TO APPLY

Stock To Buy: Heavy Engineering Stock With A 45% Upside Potential

[ad_1]

Read More/Less


What is ISGEC Heavy Engineering?

ISGEC Heavy Engineering rank 236 in the ET 500 listing, 220 in the Fortune India 500 listing. The company is into EPC projects, boilers,steel castings, sugar plant and distilleries, air pollution control equipment, contract manufacturing, presses etc. It has a rich global clientele including names like Alstom, Japan, British Petroleum, Lurgi, Foster Wheeler, North America, oshiba, Japan, Fluor, North America, Valeo, France, GM Mexico etc.

Spread over 100 hectares, the company’s manufacturing facilities cover a shop floor area of over 120,000 square meters (143520 square yards) with world class manufacturing and testing facilities.

Why to buy the stock of ISGEC Heavy Engineering Ltd?

Why to buy the stock of ISGEC Heavy Engineering Ltd?

Sharekhan sees many positives in buying the stock of the company. “Order book at Rs. 7,518 crore is 1.45x its TTM manufacturing and EPC revenue. We expect OPM to be under pressure over the next one to two quarters but expect it to normalise from FY2023 with easing commodity prices and new orders taken by the company have higher contingencies and margins. The demand environment remains buoyant both domestically and overseas, providing healthy order intake visibility,” the brokerage has said.

According to Sharekhan, the first half order inflows up 67% y-o-y while order book healthy at 1.45x its TTM manufacturing and EPC revenue.

Upside potential of 45% on the stock

Upside potential of 45% on the stock

According to the brokerage, the order pipeline remains strong both in domestic and overseas markets, which should lead to healthy order inflow going ahead.

“Moreover, the sale of Philippines plant is a major re-rating trigger. We expect the company’s strong order intake till date, positive order inflow outlook, improving execution, and rising operating cash flows to aid in healthy earnings growth for the company. The company is currently trading at a P/E of 11.5x its FY2024E EPS, which is over 40% discount to its one-year average forward PE multiple. Hence, we stay positive and expect an upside of 45%,” the brokerage has said.

Disclaimer

Disclaimer

The above stock was picked from the brokerage report of Sharekhan. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution. Greynium Information Technologies, the author, and the brokerage house are not liable for any losses caused as a result of decisions based on the article.



[ad_2]

CLICK HERE TO APPLY

1 21 22 23 24 25 387